Knowledge of recommended antibiotic treatments for community-acquired infections in general medical practice: a cross-sectional study in Occitanie region, France
- PMID: 37828124
- PMCID: PMC10570346
- DOI: 10.1038/s41598-023-43809-0
Knowledge of recommended antibiotic treatments for community-acquired infections in general medical practice: a cross-sectional study in Occitanie region, France
Abstract
To assess and analyse the knowledge of recommended antibiotic treatments, focusing on the appropriate drugs and treatment durations for the most common community-acquired infections in general medical practice in Occitanie region, France. A web-based survey was conducted over a 3-month period, from October, 2018 to January, 2019. All participants answered directly through the online platform. For the analysis of overtreatment risk, a score based system was adopted and two scores were produced: the duration score and the treatment score. 413 general practitioners completed the survey. The overall rate of concordance with guidelines in terms of both drug choice and treatment length was 2974/4956 (60%) answers. Diseases with at least 70% good answers included cystitis, group A streptococcal pharyngitis, and bacterial superficial skin infections. Diseases with fewer than 50% good answers included pyelonephritis, dog bite wounds, and community-acquired pneumonia in patients aged ≥ 65 years. Factors associated with the risk of overtreatment were age > 40 years, country setting and hospital employment. Knowledge of treatment durations is satisfactory with 60% of recommendations being met. However, varying levels were observed according to different diseases. This study highlighted a very high rate of adherence when recommendations were clear. In contrast, low levels of adherence were observed when recommendations were ambiguous or when conflicting guidelines existed.
© 2023. Springer Nature Limited.
Conflict of interest statement
The authors declare no competing interests.
References
-
- Agence nationale de sécurité du médicament et des produits de santé. Evolution des consommations d’antibiotiques en France entre 2000 et 2015 - Point d’Information. http://ansm.sante.fr/S-informer/Points-d-information-Points-d-informatio... (Accessed 14 December 2019) (2017).
-
- Gauzit R, Castan B, Bonnet E, Bru JP, Cohen R, Diamantis S, Faye A, Hitoto H, Issa N, Lebeaux D, Lesprit P, Maulin L, Poitrenaud D, Raymond J, Strady C, Varon E, Verdon R, Vuotto F, Welker Y, Stahl JP. Anti-infectious treatment duration: The SPILF and GPIP French guidelines and recommendations. Infect. Dis. Now. 2021;51(2):114–139. doi: 10.1016/j.idnow.2020.12.001. - DOI - PubMed
-
- Maugat S, Berger Carbonne A, Colomb Cotinat M, Dumartin C, Pefau M, Coignard B, Cavalie P, Hider Mlynarz K, Semaille C, Chevance A, Gay E, Moulin G, Madec JY, Brun Buisson C. Consommation d’antibiotiques et résistance aux antibiotiques en France : soyons concernés, soyons responsables. https://www.anses.fr/fr/system/files/2017_Brochure_Antibioresistance.pdf] (Accessed 4 March 2022) (2017).
-
- European Centre for Disease Prevention and Control. Antimicrobial consumption database (ESAC-Net). https://www.ecdc.europa.eu/en/antimicrobial-consumption/surveillance-and...] (Accessed 19 April 2022).
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous